Mentor Completes Acquisition of Perouse Plastie
SANTA BARBARA, Calif.--Mentor Corporation (NYSE:MNT) announced today that it has completed the acquisition of all of the outstanding shares of Perouse Plastie SAS (Perouse), a medical device company based in Bornel, France.
Mentor acquired all of the shares of Perouse for a total enterprise value of 42 million Euros, including the assumption of approximately 3 million Euros in net debt. The purchase price remains subject to customary post-closing adjustments and indemnifications.
Perouse is a rapidly growing manufacturer and distributor of silicone gel breast implants for a number of established and emerging international markets, and sells its products under the Perouse Plastie Perthese(R) brand.
About Mentor Corporation
Founded in 1969, Mentor Corporation is a leading supplier of medical products for the global aesthetic market. The Company develops, manufactures and markets innovative, science-based products for surgical and non-surgical medical procedures that allow patients to retain a more youthful appearance and improve personal well-being. The Company's website is www.mentorcorp.com.
Safe Harbor Statement
This press release contains "forward-looking statements," including statements regarding the closing of the acquisition of Perouse by Mentor and Perouse's silicone gel breast implant product offerings. These forward-looking statements are based on our current expectations, estimates and projections about our industry, management's beliefs and certain assumptions made by us. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements speak only as of the date hereof and are based upon the information available to us at this time. Such information is subject to change, and we will not necessarily inform you of such changes. These statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict.
Relevant risks and uncertainties include those referenced in Mentor's filings with the U.S. Securities and Exchange Commission, including, without limitation, its Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and recent Current Reports on Form 8-K. These filings discuss important risk factors that could contribute to differences in or otherwise affect its business, results of operations and financial condition. Risks and uncertainties relating to the Perouse acquisition include that the businesses of Mentor and Perouse will not be integrated successfully; anticipated synergies may not be fully realized or may take longer to be realized than expected; and possible disruption of the Perouse business, including with customers, employees, suppliers or third parties. These risks and uncertainties could cause actual results to differ materially and adversely from those expressed in or implied by the forward-looking statements, and should be carefully reviewed and considered. Mentor undertakes no obligation to revise or update publicly any forward-looking statement for any reason.
Contacts
Mentor Corporation
Loren L. McFarland, Chief Financial Officer
805-879-6082
Mentor acquired all of the shares of Perouse for a total enterprise value of 42 million Euros, including the assumption of approximately 3 million Euros in net debt. The purchase price remains subject to customary post-closing adjustments and indemnifications.
Perouse is a rapidly growing manufacturer and distributor of silicone gel breast implants for a number of established and emerging international markets, and sells its products under the Perouse Plastie Perthese(R) brand.
About Mentor Corporation
Founded in 1969, Mentor Corporation is a leading supplier of medical products for the global aesthetic market. The Company develops, manufactures and markets innovative, science-based products for surgical and non-surgical medical procedures that allow patients to retain a more youthful appearance and improve personal well-being. The Company's website is www.mentorcorp.com.
Safe Harbor Statement
This press release contains "forward-looking statements," including statements regarding the closing of the acquisition of Perouse by Mentor and Perouse's silicone gel breast implant product offerings. These forward-looking statements are based on our current expectations, estimates and projections about our industry, management's beliefs and certain assumptions made by us. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements speak only as of the date hereof and are based upon the information available to us at this time. Such information is subject to change, and we will not necessarily inform you of such changes. These statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict.
Relevant risks and uncertainties include those referenced in Mentor's filings with the U.S. Securities and Exchange Commission, including, without limitation, its Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and recent Current Reports on Form 8-K. These filings discuss important risk factors that could contribute to differences in or otherwise affect its business, results of operations and financial condition. Risks and uncertainties relating to the Perouse acquisition include that the businesses of Mentor and Perouse will not be integrated successfully; anticipated synergies may not be fully realized or may take longer to be realized than expected; and possible disruption of the Perouse business, including with customers, employees, suppliers or third parties. These risks and uncertainties could cause actual results to differ materially and adversely from those expressed in or implied by the forward-looking statements, and should be carefully reviewed and considered. Mentor undertakes no obligation to revise or update publicly any forward-looking statement for any reason.
Contacts
Mentor Corporation
Loren L. McFarland, Chief Financial Officer
805-879-6082
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.